1. Home
  2. UMH vs TARS Comparison

UMH vs TARS Comparison

Compare UMH & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UMH
  • TARS
  • Stock Information
  • Founded
  • UMH 1968
  • TARS 2016
  • Country
  • UMH United States
  • TARS United States
  • Employees
  • UMH N/A
  • TARS N/A
  • Industry
  • UMH Real Estate Investment Trusts
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • UMH Real Estate
  • TARS Health Care
  • Exchange
  • UMH Nasdaq
  • TARS Nasdaq
  • Market Cap
  • UMH 1.5B
  • TARS 1.4B
  • IPO Year
  • UMH N/A
  • TARS 2020
  • Fundamental
  • Price
  • UMH $18.93
  • TARS $37.07
  • Analyst Decision
  • UMH Strong Buy
  • TARS Strong Buy
  • Analyst Count
  • UMH 4
  • TARS 5
  • Target Price
  • UMH $21.25
  • TARS $51.60
  • AVG Volume (30 Days)
  • UMH 493.1K
  • TARS 530.9K
  • Earning Date
  • UMH 11-06-2024
  • TARS 11-07-2024
  • Dividend Yield
  • UMH 4.53%
  • TARS N/A
  • EPS Growth
  • UMH N/A
  • TARS N/A
  • EPS
  • UMH N/A
  • TARS N/A
  • Revenue
  • UMH $230,484,000.00
  • TARS $83,374,000.00
  • Revenue This Year
  • UMH N/A
  • TARS $846.12
  • Revenue Next Year
  • UMH $6.99
  • TARS $70.19
  • P/E Ratio
  • UMH N/A
  • TARS N/A
  • Revenue Growth
  • UMH 10.98
  • TARS 566.99
  • 52 Week Low
  • UMH $13.49
  • TARS $12.84
  • 52 Week High
  • UMH $20.64
  • TARS $42.50
  • Technical
  • Relative Strength Index (RSI)
  • UMH 45.42
  • TARS 67.74
  • Support Level
  • UMH $18.57
  • TARS $36.06
  • Resistance Level
  • UMH $19.13
  • TARS $35.62
  • Average True Range (ATR)
  • UMH 0.28
  • TARS 1.58
  • MACD
  • UMH -0.03
  • TARS 0.23
  • Stochastic Oscillator
  • UMH 32.56
  • TARS 85.33

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: